Laurence Postelmans
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Analysis of naïve Patients With Age-related Macular Degeneration of the Neovascular Type and Treated With Aflibercept (Eylea®) in "Treat-and-extend" at CHU Brugmann (NCT04891835) | Laurence Postelmans | 2021-04-13 |
| Prevalence and Risk Factors of Epiretinal Membrane in Diabetic and Non-diabetic Patients (NCT03362580) | Laurence Postelmans | 2017-12-12 |
Track Laurence Postelmans automatically
Every clearance here is in the API, with alerts when new ones post.